Search results for "Haemoglobin levels"

showing 4 items of 4 documents

Non‐invasive haemoglobin measurement as an index test to detect pre‐operative anaemia in elective surgery patients – a prospective study

2020

Non-invasive haemoglobin measurement using absolute values lacks the precision to be the sole basis for the treatment of pre-operative anaemia. However, it can possibly serve as a screening test, indexing 'anaemia' with high sensitivity when values remain under prespecified cut-off values. Based on previous data, non-invasive haemoglobin cut-off values (146 g.l-1 for women and 152 g.l-1 for men) detect true anaemia with 99% sensitivity. An index test with these prespecified cut-off values was verified by prospective measurement of non-invasive and invasive haemoglobin pre-operatively in elective surgical patients. In 809 patients, this showed an estimated sensitivity (95%CI) of 98.9% (94.1-…

AdultMalemedicine.medical_specialtyHaemoglobin levelsSensitivity and SpecificityHemoglobins03 medical and health sciences0302 clinical medicine030202 anesthesiologyInternal medicinePreoperative CareHumansMedicineProspective Studies030212 general & internal medicineElective surgeryProspective cohort studyAgedHematologic Testsbusiness.industryNon invasiveLimits of agreementIndex testAnemiaMiddle AgedPre operativeAnesthesiology and Pain MedicineElective Surgical ProceduresFemalebusinessSurgical patientsAnaesthesia
researchProduct

Calidad de la farmacoterapia y seguridad de los pacientes en hemodiálisis tratados con estimulantes eritropoyéticos

2008

Objective: To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesis-stimulating agents. Method: Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesis- stimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dl) and those with values above the safety limit (≥ 12.5g/dl) were compared every four months and the average percentage of time with haemoglobin values within the ta…

PharmacologyLongitudinal studymedicine.medical_specialtybusiness.industryHaemoglobin levelsChronic renal diseaseTarget rangePharmacotherapyInternal medicineRetrospective analysisMedicineIn patientEvery Four MonthsbusinessFarmacia Hospitalaria
researchProduct

Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective Europe…

2022

BACKGROUND Little is known about current clinical practice concerning peri-operative red blood cell transfusion in neonates and small infants. Guidelines suggest transfusions based on haemoglobin thresholds ranging from 8.5 to 12���g���dl-1, distinguishing between children from birth to day 7 (week 1), from day 8 to day 14 (week 2) or from day 15 (���week 3) onwards. OBJECTIVE To observe peri-operative red blood cell transfusion practice according to guidelines in relation to patient outcome. DESIGN A multicentre observational study. SETTING The NEonate-Children sTudy of Anaesthesia pRactice IN Europe (NECTARINE) trial recruited patients up to 60 weeks' postmenstrual age undergoing anaesthe…

Red Blood Cell TransfusionNEONATEHaemoglobin levels610 Medicine & healthPeri-operative ; red blood cell transfusion ; neonates ; infantsHigh morbidityHemoglobinsTRANSFUSIONmedicineClinical endpointHumansAnesthesiaProspective Studiesbusiness.industryPostmenstrual AgeInfant NewbornPerioperativeEuropeRed blood cellAnesthesiology and Pain Medicinemedicine.anatomical_structureAnesthesiaObservational studybusiness610 Medizin und GesundheitErythrocyte TransfusionEuropean journal of anaesthesiology
researchProduct

Pharmacotherapy quality and patient safety in haemodialysis patients treated with erythropoiesis-stimulating agents

2008

Abstract Objective To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesisstimulating agents. Method Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesisstimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dL) and those with values above the safety limit (≥12.5 g/dL) were compared every 4 months and the average percentage of time with haemoglobin values within the t…

medicine.medical_specialtyLongitudinal studybusiness.industryHaemoglobin levelsChronic renal diseaseSurgeryPatient safetyPharmacotherapyInternal medicinemedicineErythropoiesisIn patientObservational studybusinessFarmacia Hospitalaria (English Edition)
researchProduct